Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
783 participants
OBSERVATIONAL
2004-10-31
2006-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study Comparing Short Term Efficacy of Dysport and Dysport NG to Placebo, and to Assess Efficacy and Safety of Dysport NG of Subjects With Cervical Dystonia
NCT01261611
Assessment of Effectiveness and Safety of Dysport® for the Treatment of Hemifacial Spasm
NCT00276315
Comparative Study of the Effect of Dysport and Botox
NCT00434863
Study to Assess the Efficacy and Safety of Dysport® in Upper Back Myofascial Pain Syndrome
NCT00134810
Randomized, Placebo-Controlled Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical Dystonia
NCT00257660
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* scheduled to receive Dysport as per their normal treatment practice, and in conformance with their country's Summary of Product Characteristics
Exclusion Criteria
* treatment with any other investigational drug within the last 30 days before survey entry
2 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ipsen
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ipsen Medical Director
Role: STUDY_DIRECTOR
Ipsen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Saint Esprit
Agen, , France
Center Hospitalier du Pays d'Aix
Aix-en-Provence, , France
Centre Hospitalier
Chambéry, , France
Hopital Timone Adultes
Marseille, , France
Hopital Central
Nancy, , France
Hopital Hotel Dieu
Nantes, , France
Hopital Pasteur
Nice, , France
Hopital Caremeau
Nîmes, , France
Hopital Saint Antione
Paris, , France
Centre Hospitalier Pitie Salpetriere
Paris, , France
Hopital Sainte Anne
Paris, , France
Centre Hospitalier Lyon Sud
Pierre-Bénite, , France
CHU Charles Nicolle
Rouen, , France
Hopital Bellevue
Saint-Etienne, , France
Hopital Civil
Strasbourg, , France
Hopital Purpan
Toulouse, , France
Hopital Rangueil
Toulouse, , France
Praxis für Neurologie
Berlin, , Germany
Rhein. F.-Wilhelms-Universität
Bonn, , Germany
Praxis für Neurologie
Giessen, , Germany
Städt. Krankenhaus Martha-Maria
Halle-Dölau, , Germany
Neurologische Praxis
Hamburg, , Germany
Med. Hochschule
Hanover, , Germany
Bürgerhospital
Stuttgart, , Germany
E.-Karls-Universität
Tübingen, , Germany
Klinikum der Stadt Villingen-Schwenningen
Villingen-Schwenningen, , Germany
Alma-Ata State Institute of Postgraduate Education
Alma-Ata, Kazakhstan, Russia
Rehabilitation Centre "Balbulak"
Alma-Ata, Kazakhstan, Russia
Centre of plastic surgery "Reconstruction and Recreation"
Moscow, , Russia
Institute of Medical Aestetic "Vallex-M"
Moscow, , Russia
Moscow Medical Academy
Moscow, , Russia
Scientific Research Institute of Neurology
Moscow, , Russia
Cosmetological Centre "Diamond"
Moscow, , Russia
National Medical Centre of Surgery
Moscow, , Russia
Federal Centre "Pediatric Rehabilitology"
Moscow, , Russia
Centre for Aesthetic Dermatology and Surgery of Russian Academy of Sciences
Moscow, , Russia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Y-47-52120-093
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.